Patents by Inventor Ruizhi Zhao

Ruizhi Zhao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10729713
    Abstract: The present invention relates to a pharmaceutical composition for treating hepatitis, liver fibrosis, and liver cancer, which comprises the following components in parts by weight: 0.15-10 parts of vinegar-baked bupleurum root polysaccharides or bupleurum root polysaccharides and 0.05-5 parts of a drug for treating hepatitis.
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: August 4, 2020
    Assignee: GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE
    Inventors: Ruizhi Zhao, Ya Zhao, Lijuan Liu
  • Publication number: 20190099439
    Abstract: The present invention relates to a pharmaceutical composition for treating hepatitis, liver fibrosis, and liver cancer, which comprises the following components in parts by weight: 0.15-10 parts of vinegar-baked bupleurum root polysaccharides or bupleurum root polysaccharides and 0.05-5 parts of a drug for treating hepatitis.
    Type: Application
    Filed: March 24, 2017
    Publication date: April 4, 2019
    Applicant: GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE
    Inventors: RUIZHI ZHAO, YA ZHAO, LIJUAN LIU
  • Publication number: 20180289764
    Abstract: The present invention discloses a traditional Chinese medicine composition for treating psoriasis, the traditional Chinese medicine composition is prepared from materials in the following parts by weight: 5-15 parts of paeoniae radix rubra (red peony root), 3-9 parts of curcumae rhizoma (rhizoma zedoariae), 10-20 parts of sarcandrae herba (sarcandra glabra), 10-20 parts of smilacis glabrae rhizoma (glabrous greenbrier rhizome), 5-15 parts of mume fructus (black plum). The invention has the beneficial effects that the therapeutic effect can be achieved at a small dosage, the toxicity is significantly reduced, the onset is rapid, and the recurrence can be delayed. The effect is more prominent for psoriasis vulgaris (PASI50 up to 60%), especially for early onset patients.
    Type: Application
    Filed: August 19, 2016
    Publication date: October 11, 2018
    Applicant: Guangdong Provincial Hospital of Chinese Medicine
    Inventors: Chuanjian LU, Ruizhi Zhao, Guowei Xuan, Ling Han, Gengxin Chen, Yuhong Yan, Lijuan Li